Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections require subcutaneous placement—meaning the medication goes into the fatty layer beneath your skin, not into muscle. Getting injection site selection right reduces pain, prevents tissue damage, and ensures consistent medication delivery each week. PlexusDx provides detailed guidance on rotating injection locations to support your weight loss therapy.

Approved Semaglutide Injection Sites for Weekly Dosing

The FDA-approved injection sites for semaglutide include the abdomen, thigh, and upper arm. Each location has a subcutaneous fat layer thick enough to accommodate the needle safely without hitting muscle or organs. The abdomen typically has the most accessible fat tissue, making it a popular first choice for many patients starting therapy. Thighs and upper arms work equally well, offering variety when you need to rotate injection locations.

Your healthcare provider may recommend starting with one site and then rotating to others as you continue weekly injections. Rotating sites prevents lipohypertrophy—a thickening or hardening of fatty tissue that can develop with repeated injections in the same spot. This rotation strategy maintains consistent absorption rates and reduces the risk of injection-related discomfort over months of treatment.

How to Rotate Injection Sites Correctly

Effective site rotation means moving to a different body area each week rather than injecting near the same location repeatedly. If you inject into your abdomen one week, switch to your thigh the following week, then your upper arm the week after. You can return to your abdomen after a 2-3 week gap, giving the tissue time to recover. This simple pattern prevents localized tissue changes and maintains steady medication absorption.

Within each injection site, space individual injections at least one inch apart from previous injection marks. If your abdomen is your chosen rotation area, use the upper abdomen one week, lower abdomen the next week, and then alternate sides. This approach distributes the mechanical stress across a wider area of tissue, reducing inflammation and maintaining the integrity of subcutaneous fatty layers over the long term.

Technique Tips for Comfortable Semaglutide Injections

Before injecting, pinch the skin and fatty tissue at your chosen site to create a raised area roughly the size of your thumb. Insert the needle at a 90-degree angle straight into the pinched tissue, then release the skin fold once the needle is fully inserted. This pinching technique prevents the needle from accidentally hitting muscle or deeper structures, making the injection safer and often less painful. Room-temperature medication also feels less uncomfortable during injection than cold medication straight from refrigeration.

After the injection, do not rub the injection site—this can increase bruising and potentially affect medication distribution. Instead, apply gentle pressure with a clean gauze pad if needed, and allow the site to rest for a few moments. If you experience persistent redness, warmth, or a hard lump that doesn't resolve within a few days, contact your PlexusDx provider, as this may indicate an infection or tissue reaction requiring evaluation.

Why Site Selection Matters for Semaglutide Effectiveness

Subcutaneous injection sites differ in blood flow and fat-layer thickness, which can influence how quickly your body absorbs semaglutide. The abdomen generally has reliable blood supply and consistent fat depth, supporting predictable weekly absorption. The thigh and upper arm also work well, though some patients notice slightly slower onset if injected into areas with thinner subcutaneous tissue. PlexusDx compounded semaglutide achieves optimal results when injected into sites where the fat layer is at least one-quarter inch thick.

Consistent absorption supports steady appetite suppression and predictable weight loss progress week to week. Rotating sites maintains this consistency because tissue damage from repeated injections can slow medication absorption in that specific area. Starting your PlexusDx semaglutide therapy with a clear injection rotation plan helps you maximize the medication's clinical benefits and reduces the likelihood of needing dose adjustments due to absorption variability.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle instead of fatty tissue?

No—semaglutide must be injected subcutaneously into fatty tissue, not intramuscularly. Muscle injection can cause tissue damage, unpredictable absorption, and increased discomfort. Always pinch skin and fat at your chosen site and inject at a 90-degree angle to ensure proper subcutaneous placement.

What happens if I inject semaglutide in the same spot every week?

Repeated injections in one location can cause lipohypertrophy—a thickening or hardening of fatty tissue that slows medication absorption and increases bruising. Rotating sites prevents this complication and ensures consistent weekly absorption of your PlexusDx compounded semaglutide.

How much does PlexusDx compounded semaglutide cost?

PlexusDx compounded semaglutide injection starts at $149 per month across all commitment tiers, with no flat per-compound pricing increases. Your dose may need to go up. Your price won't. PlexusDx serves all 50 states without insurance or membership requirements.

Is it safe to use semaglutide if I have very little body fat?

Semaglutide requires adequate subcutaneous fat for safe injection. If you have concerns about injectable placement due to low body fat, discuss alternative options like oral semaglutide with your PlexusDx provider. A personalized treatment plan ensures safe and effective medication delivery.

Can the Precision Peptide Genetic Test help me optimize my injection sites?

The PlexusDx Precision Peptide Genetic Test identifies genetic variations affecting your GLP-1 and peptide pathways, helping predict your response to semaglutide. While it doesn't influence injection site selection directly, understanding your genetic predisposition to GLP-1 sensitivity can inform your overall treatment strategy and help ensure you're on the right medication for your biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves